Concepedia

Johan Wernevik

JW

Statistics

Publications

5

Citations

195

H-Index

5

Active since

2006

Affiliations

AstraZeneca (Sweden)(Current)

AstraZeneca (Japan)

AstraZeneca (Singapore)

AstraZeneca (Germany)

Johan Wernevik is an author at AstraZeneca (Sweden) specializing in pharmacy, drug discovery, and pharmacology.

ORCID

Publications per year

2006–2024

5

Publications

5

Presentation of a Structurally Diverse and Commercially Available Drug Data Set for Correlation and Benchmarking Studies

Christian Sköld, Susanne Winiwarter, Johan Wernevik et al. · Journal of Medicinal Chemistry · 2006 · 55 citations

, , +10

Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction Mixtures

Mateusz P. Plesniak, Emilia K. Taylor, Frederik Eisele et al. · ACS Medicinal Chemistry Letters · 2023 · 49 citations · Full text

, , +14

Fluorine‐Directed Glycosylation Enables the Stereocontrolled Synthesis of Selective SGLT2 Inhibitors for Type II Diabetes

Anna Sadurní, Gerald Kehr, Marie Ahlqvist et al. · Chemistry - A European Journal · 2017 · 41 citations

, , +15

A Fully Integrated Assay Panel for Early Drug Metabolism and Pharmacokinetics Profiling

Johan Wernevik, Fredrik Bergström, Anna Novén et al. · Assay and Drug Development Technologies · 2020 · 39 citations · Full text

, , +16

Closing the Design–Make–Test–Analyze Loop: Interplay between Experiments and Predictions Drives PROTACs Bioavailability

Zulma Santisteban Valencia, Jennifer Kingston, Filip Miljković et al. · Journal of Medicinal Chemistry · 2024 · 11 citations

, , +15

1–5 of 5